Prevalence of Colonization with Multidrug-Resistant Bacteria: Results of a 5-Year Active Surveillance in Patients Attending a Teaching Hospital

Author:

Quirino Angela1,Cicino Claudia1,Scarlata Giuseppe Guido Maria1ORCID,Marascio Nadia1ORCID,Di Gennaro Gianfranco2ORCID,Matera Giovanni1,Licata Francesca2ORCID,Bianco Aida3ORCID

Affiliation:

1. Unit of Clinical Microbiology, Department of Health Sciences, University of Catanzaro “Magna Græcia”, 88100 Catanzaro, Italy

2. Department of Health Sciences, School of Medicine, University of Catanzaro “Magna Græcia”, 88100 Catanzaro, Italy

3. Department of Medical and Surgical Sciences, School of Medicine, University of Catanzaro “Magna Græcia”, 88100 Catanzaro, Italy

Abstract

Combating antimicrobial resistance (AMR) requires comprehensive efforts, such as screening to identify patients colonized by multidrug-resistant microorganisms (MDROs). The primary purpose of this study was to estimate the AMR pattern of methicillin-resistant Staphylococcus aureus (MRSA) isolated from nasal surveillance swabs and MDROs isolated from pharyngeal and rectal surveillance swabs in patients attending a teaching hospital. Data were sought retrospectively, from 1 January 2017 to 31 December 2021, from the records produced by the hospital microbiology laboratory. Duplicate isolates, defined as additional isolates of the same microorganism with identical antibiograms, were excluded. Among Staphylococcus aureus isolates from nasal swabs, 18.2% were oxacillin-resistant. Among Gram-negative bacteria, 39.8% of Klebsiella pneumoniae and 83.5% of Acinetobacter baumannii isolates were carbapenem-resistant. Resistance to three antibiotic categories was high among Acinetobacter baumannii (85.8%) and Klebsiella pneumoniae (42.4%). The present data highlight a high prevalence of MDRO colonization among patients admitted to the hospital and suggest that screening for MDROs could be an important tool for infection control purposes, especially in geographical areas where limiting the spread of MDROs is crucial. The results also underline the importance of active surveillance, especially for carbapenem-resistant, Gram-negative bacteria in reducing their transmission, especially in high-risk units.

Publisher

MDPI AG

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Pharmacology, Toxicology and Pharmaceutics,Biochemistry,Microbiology

Reference55 articles.

1. Global Burden of Bacterial Antimicrobial Resistance in 2019: A Systematic Analysis;Murray;Lancet,2022

2. European Centre for Disease Prevention and Control (2016). Rapid Risk Assessment: Carbapenem-Resistant Acinetobacter baumannii in Healthcare Settings—8 December 2016, European Centre for Disease Prevention and Control.

3. European Centre for Disease Prevention and Control (2019). Carbapenem-Resistant Enterobacteriaceae, Second Update—26 September 2019, European Centre for Disease Prevention and Control.

4. Prevalence of Antibiotic Resistance Over Time in a Third-Level University Hospital;Scaglione;Microb. Drug Resist.,2022

5. Cerini, P., Meduri, F.R., Tomassetti, F., Polidori, I., Brugneti, M., Nicolai, E., Bernardini, S., Pieri, M., and Broccolo, F. (2023). Trends in Antibiotic Resistance of Nosocomial and Community-Acquired Infections in Italy. Antibiotics, 12.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3